C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2004
12/09/2004	US20040248175 Embryogenic regulatory protein for use in diagnosis, prevention and treatment of cell proliferative and reproductive disorders
12/09/2004	US20040248174 Small interfering RNA sequences for use in prevention and treatment of vision defects, inflammation, cardiovascular and cell proliferative disorders; RNA interference; gene expression inhibition
12/09/2004	US20040248173 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder
12/09/2004	US20040248171 Using hypermethylation of regulatory protein gene sequences has diagnostic indicator of breast, lung and colon cancers
12/09/2004	US20040248168 Nucleotide sequences coding homeodomain-interacting protein kinase (HIPK) for use as tool in identifying antisense agent for use in treatment of nervous system and brain disorders
12/09/2004	US20040248167 Multicompartment apparatus for the rapid detection of DNA, proteins and viruses
12/09/2004	US20040248165 Nucleic acid immobilization method and manufacturing method of biosensor using same
12/09/2004	US20040248164 Preparing microarray comprised of short hairpin looped RNA molecules for use in monitoring gene expression in mammalian cells; high throughput assay for use in functional genomics; post transcriptional gene silencing
12/09/2004	US20040248162 Releasable polymer arrays
12/09/2004	US20040248159 Plant farnesyltransferases
12/09/2004	US20040248155 Novel oncogene, recombinant protein derived therefrom, and uses thereof
12/09/2004	US20040248154 Hormone transcription factor for use in identifying tissue-selective estrogens and controlling heterologous gene expression
12/09/2004	US20040248153 Determining linkage realtionships between preferential genes along a chromosome; genetic engineering and linkage relationships
12/09/2004	US20040248149 Nucleotide sequences coding G-protein coupled receptor (T2R) for use in identifying modulators which control bitterness; food processing and pharmocological design
12/09/2004	US20040248148 Ultrasensitive detection of pathogenic microbes
12/09/2004	US20040248145 Using vector transformation to generate transgenic cells which overexpress an enzyme which specifically digests RNA/DNA hybrids; gene expression inhibition via nuclease digestion and antisense oligonucleotide exposure
12/09/2004	US20040248143 Generating novel polypeptides via non-stochastic polynucleotide site-saturation mutagenesis; protein bioengineering
12/09/2004	US20040248142 Method for detecting hepatocellular carcinoma
12/09/2004	US20040248141 Transgenic cell comprising nucleotide sequences which form triplex structures for use in diagnosis, prevention and treatment of skin, pigmentation and cell proliferative disorders
12/09/2004	US20040248140 Nucleotidic sequences having activity of controlling translation efficiency and utilization thereof
12/09/2004	US20040248137 Human and mammalian stem cell-derived neuron survival polypeptides
12/09/2004	US20040248133 Method for determining cell cycle position
12/09/2004	US20040248132 Regulatory sequences which control expression from seven in absentia homologue-1(siah-1) and death receptor 5 (DR5) for use in identifying modulators of apoptosis and cell proliferative; antitumor agents
12/09/2004	US20040248131 Methods for dna mutagenesis and dna cloning
12/09/2004	US20040248130 Nucleic acid extraction device
12/09/2004	US20040248129 Neural polypeptide for use as tool in identifying modulators for controlling body weight; treating obesity
12/09/2004	US20040248126 Method of detecting toxic substance
12/09/2004	US20040248124 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
12/09/2004	US20040248123 Membrane protein receptor for use in identifying modulator of taste; point mutations; antibodies; food processing and bitterness; phenotype analysis
12/09/2004	US20040248122 Comprises substrate presenting reflecting main surface with localized sites (containing halogen, silane, or silanol groups) which are sensitive to fluorescence detection by transparent layer; microarrays; improved fluorescence
12/09/2004	US20040248121 Transgenic myocytes as tool in monitoring myostatin inhibitory activity on gene expression; tissue and musle regeneration; diagnosing and treating muscle disorders
12/09/2004	US20040248119 Dna fragments containing gene having function relating to autonomous proliferation of plasmid
12/09/2004	US20040248115 Nucleotide sequence probes for detecting beer-spoilage lactic acid bacteria; food processing and alcoholic beverages
12/09/2004	US20040248114 Novel maxizyme
12/09/2004	US20040248113 Expression vector comprising immunoglobulin sequences for treatment and prevention of infections and cell proliferative disorders; minigene vaccines; immunotherapy
12/09/2004	US20040248110 Random truncation and amplification of nucleic acid
12/09/2004	US20040248109 Methods for selecting protein binding moieties
12/09/2004	US20040248102 Replicating RNA sequences using template mediated primer extension; preparing labeled nucleic acid for monitoring differential gene expression
12/09/2004	US20040248101 Identification of novel antibacteria agents by screening the single-stranded DNA expression library
12/09/2004	US20040248099 Calcium-activated potassium channels; 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives act as inhibitors; gene knockout; skin disorders; psoriasis; wound healing
12/09/2004	US20040248098 Using rearrangements in microsatellite sequences (numbers present) detected via variation in mass to charge ratio to identify genomic polymorphism
12/09/2004	US20040248091 Novel polypeptide-human g-protein and the polynucleotide encoding the same
12/09/2004	US20040248088 Novel g protein-coupled receptor up-regulated in prostate cancer and uses thereof
12/09/2004	US20040248087 Using specific oligonucleotide primers to enrich isothermal amplification reaction products with preferential nucleotide sequences; DNA amplification
12/09/2004	US20040248083 Viral plasmid comprising heterologous or synthetic dimerisation sequences which promotes dimer formation of plasmid transcripts and prevents recombination between plasmid transcripts and another retrovirus present in genome; gene transfer tool; bioreactor
12/09/2004	US20040247680 Targeted delivery of controlled release polymer systems
12/09/2004	US20040247661 injectable liposomal composition for delivery of large amounts of water-soluble substance comprises a plurality of liposomal vesicles having a high weight ratio of lipid to encapsulated water-soluble substance which is distributed over the liposomal vesicles; high efficiency of encapsulation
12/09/2004	US20040247621 Combination therapy using a synergistic mixture of mechlorethamine, nitrogen mustard N-oxide, melphalan, uramustin, ifosfamide, chlorambucil, or cyclophosphamide and an anti-interleukin-6 receptor antibody; anticarcinogenic agents
12/09/2004	US20040247620 Genetic transduction for improved exogenous gene expression of epothilones in a modified host cell
12/09/2004	US20040247616 Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof
12/09/2004	US20040247615 A nucleic acid comprising a nucleotide sequence encoding a Met-NS3-NS4A-NS4B-NS5A-NS5B polypeptide containing an inactive NS5B RNA-dependent RNA polymerase region; adenovector or DNA plasmid vaccine; cultured cells expressing the nucleic acid; vaccination
12/09/2004	US20040247613 A nucleic acid expression vector encodes the catalytic subunit of human telomerase reverse transcriptase (hTRT); immunostimulants; anticarcinogenic agents; gene therapy
12/09/2004	US20040247601 Methods for diagnosing cancer and decreasing metastasis by cancer cells
12/09/2004	US20040247600 Agent that specifically binds to human MTAP protein in an embedded biological sample, especially a polyclonal antibody or a monoclonal antibody produced by hybridoma cell line ATCC Accession No. PTA-5001
12/09/2004	US20040247595 Related to the potassium channel subfamily; can be used as models for the development of and aid in the identification of therapeutic proteins that modulate transporter activity
12/09/2004	US20040247585 Recombinant alpha-galactosidase a therapy for fabry disease
12/09/2004	US20040247583 Capable of producing d-pseudoephedrine by acting on l-2-methylaminopropiophenone; a nucleic acid coding the enzyme, a microorganism producing the enzyme, and producing an optically active aminoalcohol using them
12/09/2004	US20040247578 Administering into or near a site of a tumor or infectious lesion an antigen presenting cell, especially a dendritic cell, and an immunostimulatory cytokine or a nucleic acid encoding an immunostimulatory cytokine
12/09/2004	US20040247572 Hair follicle-reconstitution system and animal carrying the same
12/09/2004	US20040247564 Treating a tissue disorder involving a loss and/or apoptosis of cells by administering an agent that induces phosphorylation and/or activation of protein kinase B to cause proliferation; particularly administering a human stromal-derived factor-1 and a G-CSF to cause proliferation of cardiomyocytes
12/09/2004	US20040247562 Diagnostic and prognostic method for cancer based on skipping of the exon 3 region of the G-CSF gene at mRNA or protein levels
12/09/2004	US20040245317 Artificial chromosomes that can shuttle between bacteria yeast and mammalian cells
12/09/2004	US20040245209 Covering a catalyst thin film with a supramolecule thin film; self-assembling by annealing; selectively staining with a metal compound and etching an unstained portion using stained film as a mask to form stained supramolecule nanopattern and using it to form a nanopattern of the catalyst by ion-milling
12/09/2004	US20040245163 Purification device for ribonucleic acid in large volumes, and method
12/09/2004	US20040244714 Methods for growing and imprinting fish using an odorant
12/09/2004	US20040244623 Printed materials comprising a support having an oligomer and/or a polymer applied thereon, a method for preparing the same and a method for delivering and/or storing the same
12/09/2004	DE10314413A1 Verfahren zum Nachweis der Expression rekombinanter Proteine an einer Zelloberfläche und zur Immobilisierung und Aufreinigung von Zellen und Proteinen A method for detecting the expression of recombinant proteins on a cell surface and for immobilization and purification of proteins and cells
12/09/2004	DE102004019852A1 New modified sarcosine oxidase, useful for assaying creatinine, e.g. for diagnosis of kidney disease, has improved stability under acidic conditions, also new DNA that encodes it
12/09/2004	CA2527907A1 Double-stranded hairpin rnas for rnai
12/09/2004	CA2527819A1 Optical sensors based on hybrid aptamer/conjugated polymer complexes
12/09/2004	CA2527722A1 Biodegradable poly(beta-amino esters) and uses thereof
12/09/2004	CA2527571A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
12/09/2004	CA2527429A1 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
12/09/2004	CA2527301A1 Oligonucleic acid-bearing composite and pharmaceutical composition containing the composite
12/09/2004	CA2527216A1 Process for obtaining plasmid dna by means of an aqueous 2-phase system
12/09/2004	CA2527115A1 Wheat plants having increased tolerance to imidazolinone herbicides
12/09/2004	CA2527109A1 Oligo double-stranded rna inhibiting the expression of bcl-2 and medicinal composition containing the same
12/09/2004	CA2526695A1 Selection of allosteric regulators with class iii g protein-coupled receptors depleted of the extracellular domain
12/09/2004	CA2526083A1 Complement inhibitors
12/09/2004	CA2525853A1 Method for cloning in the rat by nuclear transfer
12/09/2004	CA2525717A1 Gitr ligand and gitr ligand-related molecules and antibodies and uses thereof
12/09/2004	CA2525540A1 Enterococcus antigens
12/09/2004	CA2524454A1 Enzyme with xylanase activity at acidic ph
12/09/2004	CA2523716A1 Human anti-human cd3 binding molecules
12/09/2004	CA2521331A1 Novel il-8-like polypeptides
12/08/2004	EP1484699A2 Protein design automation for protein libraries
12/08/2004	EP1484415A2 Method of alleviating pest infestation in plants
12/08/2004	EP1484412A2 Eukaryotic host cell line in which an endogenous gene has been activated, and uses thereof
12/08/2004	EP1484411A1 Stress resistant plant
12/08/2004	EP1484410A1 Fermentation methods and genetically modified bacteria with increased substrate and byproduct uptake.
12/08/2004	EP1484409A2 Expression vector comprising short-lived drug resistance gene
12/08/2004	EP1484408A1 Human kinase proteins and polynucleotides encoding the same
12/08/2004	EP1484407A1 Method of controlling ethanol production and mass production of lactic acid and transformant therefor
12/08/2004	EP1484405A1 Nucleic acid fragments and polypeptide fragments derived from M. Tuberculosis
12/08/2004	EP1484404A1 Immunogenic detoxified mutants of cholera toxin and of the toxin LT, their preparation and their use for the preparation of vaccines
12/08/2004	EP1484403A1 Gene participating in the synthesis of brassinosteroid
12/08/2004	EP1484402A2 Antibody for use in therapy
12/08/2004	EP1484401A1 Secreted polypeptides and corresponding polynucleotides
12/08/2004	EP1484400A1 Sodium-independent transporter carrying acidic amino acid and its gene
12/08/2004	EP1484399A1 Mouse spermatogenesis genes, human male sterility-associated genes and diagnostic system using the same

1 ... 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 2131 2132 2133 2134 2135 2136 2137 2138 2139 2140 2141 ... 4023